The Nanotechnology Institute at the Jordan University of Science and Technology organized a scientific lecture today, Tuesday, titled "Biogenic Drug Delivery Systems Using Nanotechnology Techniques" This event is part of the activities of the Abdul Hameed Shoman Foundation, which hosts a select group of pioneering Arab scientists in the fields of science and technology, in collaboration with the Arab Bank.

The event was attended by a representative of the University President, Vice President Prof. Dr. Mona Abu Dalo, along with several deans, faculty members, researchers, and students interested in nanotechnology and pharmaceutical sciences.

The University hosted Prof. Dr. Khulood Al-Jamal, Professor of Pharmacy at the University of Hong Kong and Head of the Department of Pharmacology and Pharmacy, during the event. She is one of the world's leading researchers in nanotherapeutics for developing treatments for neurological disorders and cancer. She has published over 170 scientific papers and received prestigious international awards, including the Royal Pharmaceutical Society Medal from the British Royal Pharmaceutical Society and the Wellcome Trust Award for Scientific Imaging.

Prof. Dr. Rania M. Hathout, Professor and Head of the Pharmaceutics Department at Ain Shams University, also participated. She is the recipient of the 2025 Abdul Hameed Shoman Award for Arab Researchers and a pioneer in computational pharmaceutics and nanotechnology. Ranked among the top 2% of scientists worldwide, she has presented over 100 scientific papers on drug delivery systems and cancer treatment, and has received numerous Arab and international awards.

During the lecture, Dr. Al-Jamal delivered a presentation titled "My Journey into Nanotechnology for Medicine," in which she reviewed her research experience in employing nanotechnology in medicine and how nanoengineering has revolutionized disease diagnosis and treatment at the molecular and cellular levels.

Dr. Hathout presented her lecture titled "Towards Intelligent Nanomedicines: Exploring Stimuli-Responsive Drug Delivery and Nano-Onco-Immunotherapy," covering the latest developments in designing smart drugs capable of responding to specific biological stimuli and their applications in immuno-oncology for cancer tumors.

Prof. Dr. Mohammd-Ali Al-Omari, Dean of the Nanotechnology Institute at the University, affirmed that the Institute is one of the leading research centers in the region, featuring advanced infrastructure and laboratories focused on nanotechnology applications in medicine, engineering, energy, and the environment. He noted that organizing such scientific gatherings reflects the University's commitment to supporting scientific research, fostering academic and research collaborations with Arab and international scientists, and contributing to the development of innovative solutions that serve society and support sustainable development.

The event concluded with an interactive scientific discussion between the researchers and attendees, during which experiences and future visions regarding the potential applications of nanotechnology in developing modern biotherapeutics were exchanged.

​